Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00938665 · ClinicalTrials.gov registry record
Evaluation of a Handheld Event Related Potential (ERP)/Quantitative Electroencephalography (qEEG) System (COGNISION™) as a Useful Cognitive Biomarker for Alzheimer's Disease.
A clinical trial, sponsored by Neuronetrix.
- Completed
- Registry status
- 204
- Enrollment target
NCT00938665: Completed study, sponsored by Neuronetrix.
NCT00938665 is a clinical trial that has completed, run by Neuronetrix. The registered enrollment target is 204 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00938665 has completed, sponsored by Neuronetrix.
- COMPLETED
- Registry status
- 204 participants
- Enrollment target
Study Summary
The proposed study is designed to evaluate the performance of the COGNISION™ System as a tool to assist physicians in diagnosing Alzheimer's Disease (AD) in real-world clinical settings. The design of this study is guided by two overriding factors: 1) to optimize the performance of the event related potentials (ERP) classifiers, the subjects making up the training sets must be well characterized as to their clinical diagnosis, and 2) all ERP tests must be performed and reproduced in real-world clinical settings.
Interventions
- DEVICE COGNISION™ System
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 204 participants |
| Start Date | 2010-12 |
| Est. Completion | 2014-02 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00938665
The ClinicalTrials.gov registry entry for NCT00938665 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 204 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Neuronetrix, which has 4 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which COGNISION™ System is the first listed.
NCT00938665 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00938665 about?
NCT00938665 is a clinical study titled "Evaluation of a Handheld Event Related Potential (ERP)/Quantitative Electroencephalography (qEEG) System (COGNISION™) as a Useful Cognitive Biomarker for Alzheimer's Disease.". The proposed study is designed to evaluate the performance of the COGNISION™ System as a tool to assist physicians in diagnosing Alzheimer's Disease (AD) in real-world clinical settings. The design of this study is guided by two overriding factors: 1) to optimize the performance of the event related...
What is the current status of trial NCT00938665?
This trial is currently completed. The enrollment target is 204 participants. The study started on 2010-12. Estimated completion is 2014-02.
What interventions are being tested in trial NCT00938665?
The interventions under investigation include: COGNISION™ System (DEVICE).
Who is sponsoring clinical trial NCT00938665?
This trial is sponsored by Neuronetrix, which has 4 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.